AKT1 and hepatocellular carcinoma: YAP5SA is a constitutive active YAP similar to the above described YAP2SA mutant but with three additional LATS1/2 sites mutated from S to A. The expression of YAP5SA and myr-AKT results in formation of multifocal hepatocellular carcinoma [23].